Cellectis - ADR (CLLS) Company Profile & Statistics

Cellectis - ADR
CLLS
(Nasdaq - US)
N/A
2.52
+0.02 (+0.80%)
in:usd•As of: Apr 25, 2024 12:59 UTC -4
Open
2.47
High
2.52
Low
2.47

About Cellectis - ADR

CEO

Andr¿ Choulika

Headquarters

8 rue de la croix jarry

paris, i0 75013, france

Auditor

Ernst & Young et Autres

Employees

237

Share Holders

N/A

Website

www.cellectis.com

Industry

pharmaceuticals major

Sector

health technology

Company Overview

Cellectis SA is a gene-editing company. The company focused on developing immunotherapies based on gene edited engineered CAR-T cells. Cellectis SA is based in Paris, France.

Cellectis - ADR Statistics

Valuation Measures

Market Capitalization ²	140.06M
Enterprise Value	121.01M
Enterprise Value/EBITDA (ttm)	-2.18
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	1.91
Price to Sales (ttm)	5.94
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	93.22%
Operating Margin (ttm)	-311.98%
Profit Margin (ttm)	-648.83%
Return on Equity (ttm)	-73.03%
Return on Invested Capital (ttm)	-57.69%
Return on Assets (ttm)	-32.22%

Income Statement

Revenue (ttm)	24.53M
Revenue Per Share (ttm)	N/A
Gross Profit (ttm)	23.27M
EBITDA (ttm)³	-55.46M
Net Income Avi to Common (ttm)	-85.02M
Diluted EPS (ttm)	-1.67

Share Statistics

Beta (5Y Monthly)	3.12
52-Week Change	29.90%
S&P500 52-Week Change	23.96%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	N/A
Dividend Yield	0.00%
Float ⁴	46.46M
% Held by Insiders	16.41%
% Held by Institutions	63.90%

Balance Sheet

Total Cash (mrq)	67.36M
Total Cash Per Share (mrq)	N/A
Total Debt (mrq)	48.31M
Total Debt/Equity (mrq)	63.46%
Current Ratio (mrq)	2.20%
Quick Ratio (mrq)	2.20%
Book Value Per Share (mrq)	1.37

Cash Flow

Operating Cash Flow Per Share (ytd)	-1.16
Free Cash Flow (ytd)	-65.26M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Cellectis - ADR

Trade With A Regulated Broker